Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2007-02-28
2009-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Project ACCEPT: Engaging Newly Diagnosed HIV+ Youth in Care
NCT01751620
Intervention Development for Newly Diagnosed Youth With HIV
NCT00255892
Confidential Care and Adolescent HIV Testing
NCT06279949
ID and Testing Via Friendship Networks
NCT00841360
Engaging Care for HIV-infected Adolescent Females.
NCT00489034
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Individual Session I: Orientation I
Part A - meet with interventionist for ecological assessment, rapport building, and preparation for meeting with medical provider Part B - meet with medical provider to answer HIV specific medical questions (i.e., transmission information, viral load/t-cells, opportunistic infections,etc.). The interventionist will be present in Part B as well.
Individual Session II: Orientation II
Part A - meet with interventionist for continued debriefing, question/answer, preparation for group participation.
Part B - meet with peer facilitator to discuss individual experiences living with HIV, rapport building, peer-specific questions. The interventionist will be present in Part B as well.
Individual session III: Wrap-up and Action Planning (to take place after group sessions are complete)
Part A - action plan with linkage to identified agencies via facilitated referrals Part B - (optional) support building - participants may bring parents, partner, friend, or other potential source of support for question/answer session with interventionist
Session I: Developing Group Cohesion
\- Icebreaker, team building, group rules, facilitation of group "ownership" by participants.
Session II: Disclosure, Stigma \& Relationships
* Disclosure to family, friends, peers and co-workers as well as dealing with stigma associated with HIV/AIDS;
* Concerns about current or future romantic and/or sexual relationships, including discussion of safer sex, condom use, sero-discordant couples.
Session III: Preparing for Medical Intervention
\- Working with medical providers, an overview of clinic appointments and expectations surrounding attendance, a preliminary discussion of medications, side effects, and medical management as well as strategies for adherence.
Session IV: Healthy Living
* Issues related to drugs and alcohol;
* Leisure activities such as sports and entertainment;
* Self-care including nutrition and exercise;
* The importance of school and work.
Session V: Stress Reduction/Relaxation \& Spirituality
* Techniques including deep breathing, progressive muscle relaxation, visualization, meditation and self-hypnosis;
* Self-care including complimentary therapies such as massage and acupuncture
* Spirituality;
* Planning social outings and activities.
Session VI: Gender Specific
* Males: issues surrounding sexuality and sexual orientation, male role of caring for self, loved ones, and the community;
* Females: issues surrounding sexuality, pregnancy and parenting, female role of caring for self, loved ones, and the community.
Session VII: Self-Esteem/Self-Worth
\- Strategies to improve self-esteem and self-worth;
Session VIII: Legal Issues/Advocacy
* Legal rights and advocacy;
* Linkage to community advocacy groups;
* Preparing to become a speaker/advocate;
* Health insurance/life insurance.
Session IX: Future Planning
\- Planning for the future including issues related to work and school (e.g., job application process, applying for financial aid), job training and career choices.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
5-7 females per group at each of the four sites.
"Adolescents Coping, Connecting, Empowering, and Protecting Together" (Project ACCEPT)
The intervention will consist of a combination of individual and group-based sessions in which the youth will participate. This combination allows for more intensive individualized attention as well as supportive group sessions. Youth will first participate in two individual sessions, followed by nine group sessions, and end with one additional individual session.
2
5-7 males per group at each of the four sites.
"Adolescents Coping, Connecting, Empowering, and Protecting Together" (Project ACCEPT)
The intervention will consist of a combination of individual and group-based sessions in which the youth will participate. This combination allows for more intensive individualized attention as well as supportive group sessions. Youth will first participate in two individual sessions, followed by nine group sessions, and end with one additional individual session.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
"Adolescents Coping, Connecting, Empowering, and Protecting Together" (Project ACCEPT)
The intervention will consist of a combination of individual and group-based sessions in which the youth will participate. This combination allows for more intensive individualized attention as well as supportive group sessions. Youth will first participate in two individual sessions, followed by nine group sessions, and end with one additional individual session.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Receive services at one of the 4 selected ATN sites or their community partners;
* HIV-infected as documented by medical record review or verbal verification with referring professional;
* Received HIV diagnosis less than 15 months ago as documented by medical record review or verbal verification with referring professional;
* Fall between the ages of 16-24 (inclusive) at the time of informed consent/assent;
* Must be willing to participate in the both the individual and group sessions;
* Give informed consent/assent for study participation.
Exclusion Criteria
* Presence of serious psychiatric symptoms (active hallucinations, thought disorder);
* Visibly distraught (suicidal, homicidal, exhibiting violent behavior);
* Intoxicated or under the influence of alcohol or other substances at the time of study enrollment.
16 Years
24 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
National Institute of Mental Health (NIMH)
NIH
University of North Carolina, Chapel Hill
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sybil Hosek, PhD
Role: STUDY_CHAIR
John Stroger Jr. Hospital of Cook County
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Miami School of Medicine
Miami, Florida, United States
John Stroger Jr. Hospital of Cook County
Chicago, Illinois, United States
Montefiore Medical Center
The Bronx, New York, United States
St. Jude Children's Research Hospital
Memphis, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Website for the Adolescents Trials Network for HIV/AIDS Interventions
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ATN 068
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.